share_log

CytoDyn Settles With Amarex Clinical Research; Amarex To Pay $12M To CytoDyn, $10M Was Paid Upon Execution Of Agreement And Remainder To Be Paid Next 12 Months; Eliminates $14M Accounts Payable Liability From Balance Sheet

CytoDyn Settles With Amarex Clinical Research; Amarex To Pay $12M To CytoDyn, $10M Was Paid Upon Execution Of Agreement And Remainder To Be Paid Next 12 Months; Eliminates $14M Accounts Payable Liability From Balance Sheet

CytoDyn與Amarex Clinical Research達成和解;Amarex將向CytoDyn支付1200萬美元,其中1000萬美元已在協議執行時支付,其餘部分將在接下來的12個月內支付;從資產負債表中消除1400萬美元應付賬款負債。
Benzinga ·  07/09 20:38

Terms of the settlement include $12,000,000 cash payment to CytoDyn and elimination of $14,000,000 accounts payable liability from the Company's balance sheet

和解條款包括支付給CytoDyn 1200萬美元現金,並從公司資產負債表中消除1400萬美元應付賬款責任。

譯文內容由第三人軟體翻譯。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
    搶先評論